Nanoparticle and its Relevance: A Reassessment


  • Chetan Rastogi Department of Biochemistry, King George Medical University, Lucknow, Uttar Pradesh, India.
  • Nishi Shukla Department of Pharmacognosy, Babu Banarasi Das Northern India Institute of Technology, Lucknow, Uttar Pradesh, India.
  • Shivjee Kashyap Department of Pharmaceutical Chemistry, KJ College of Pharmacy, Varanasi, Uttar Pradesh, India.
  • Abhishek Raj Pharma Talk Research Foundation, Lucknow, Uttar Pradesh, India.
  • Shravan Kumar Paswan Pharma Talk Research Foundation, Lucknow, Uttar Pradesh, India.
  • Pritt Verma Pharma Talk Research Foundation, Lucknow, Uttar Pradesh, India.


Aim: To extent awareness of nanoparticles and their application.
Objective: Synthesis of nanoparticles and their determination of properties and size are most prominent in drug development as well as pharmaceutical research. To understand the concept behind this technique is necessary to understand the nanoparticles and its technical
Background: From many years, nanoparticles and its development for various research to target the drug and its delivery on targeted site is booming in the treatment of various disease in the current scenario. So, these techniques are utilized to change the pharmacokinetics and pharmacodynamics and release of drug delivery at a particular time.
Reason: Awareness related to the research of nanoparticles in pharmaceutical research as well as the drug industry.

How to cite this article: Rastogi C, Shukla N, Kashyap S et al. Nanoparticle and its Relevance: A Reassessment. Rec Trends Pharm Tech Ind 2020; 2(1): 12-19.


Orive G. Drug delivery in biotechnology: Present and future. Current Opinion in Biotechnology. 2003; 14: 659-664.

Davis SS, Illume L. International Journal of Pharmacology 1998; 176: 1-8.

Raj MVJ, Chen Y. Nanoparticles – Pharmaceutical Research. 2006.

Langer R. Biomaterials in drug delivery and tissue engineering. 2003; 101.

Bhadra D, Bhadra S, Jain P et al. Pegnology: a review of PEG-ylated systems. Pharmazie 2002; 57: 5-29.

Kommareddy S, Tiwari SB, Amiji MM. Long circulating polymeric, 2005.

Lee M, Kim SW. Polyethylene glycol-conjugated copolymers for plasmid DNA delivery. Pharm Res 2005; 22: 1-10.

Vila A, Sanchez A, Tobio M et al. Design of biodegradable. 2002.

Mu L, Feng SS. A novel controlled release formulation for the anticancer drug Paclitaxel (nanoparticles containing vitamin E TPGS. J). 2003.

In Colloidal drug delivery systems. J. K. Ed. Marcel Dekker: New York, 342, 1994.

Adami R. Nanomaterials. The Journal of Supercritical Fluids 2006.

Rolland JP, Maynor BW, Denison GM. Direct fabrication 2005; 127.

Kompella. Poly (lactic acid) nanoparticles for sustained release of budesonide. 2001.

Kwon HY, Lee JY, Choi SW et al. Preparation of PLGA. 2001; 130.